Modulation effect of filamentous phage on α-synuclein aggregation

Biochemical and Biophysical Research Communications

Volumn 383, Issue 4, 2009, Pages 491-496

  Dimant, Hemi ^a   Sharon, Noa ^a   Solomon, Beka ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Synuclein; Aggregation; Amyloid; Conformation; Filamentous phage; Oligomers; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; ARGINYLGLYCYLASPARTIC ACID;

ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FILAMENTOUS PHAGE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; NEUROBLASTOMA CELL; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ALPHA-SYNUCLEIN; CELL LINE, TUMOR; HUMANS; INOVIRUS; MODELS, BIOLOGICAL; NANOSTRUCTURES; OLIGOPEPTIDES; PARKINSON DISEASE;

MAMMALIA;

EID: 65449185792     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.048     Document Type: Article

References (13)

1. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2 (2001) 492-501
2. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., De Silva H.A., Kittel A., and Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 (1995) 467-475
3. Giasson B.I., Murray I.V., Trojanowski J.Q., and Lee V.M. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J. Biol. Chem. 276 (2001) 2380-2386
4. Marvin D.A. Filamentous phage structure, infection and assembly. Curr. Opin. Struct. Biol. 8 (1998) 150-158
5. Zhong G., Smith G.P., Berry J., and Brunham R.C. Conformational mimicry of a chlamydial neutralization epitope on filamentous phage. J. Biol. Chem. 269 (1994) 24183-24188
6. Hart S.L., Knight A.M., Harbottle R.P., Mistry A., Hunger H.D., Cutler D.F., Williamson R., and Coutelle C. Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J. Biol. Chem. 269 (1994) 12468-12474
7. El-Agnaf O.M.A., Salem S.A., Paleologou K.E., Curran M.D., Gibson M.J., Court J.A., Schlossmacher M.G., and Allsop D. Detection of oligomeric forms of {alpha}-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J. 20 (2006) 419-425
8. Hasegawa T., Matsuzaki M., Takeda A., Kikuchi A., Akita H., Perry G., Smith M.A., and Itoyama Y. Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. Brain Res. 1013 (2004) 51-59
9. Volles M.J., Lee S.J., Rochet J.C., Shtilerman M.D., Ding T.T., Kessler J.C., and Lansbury Jr. P.T. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40 (2001) 7812-7819
10. Conway K.A., Lee S.J., Rochet J.C., Ding T.T., Williamson R.E., and Lansbury Jr. P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA 97 (2000) 571-576
11. B. Solomon, Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment, US Neurol., in press.
12. Frenkel D., and Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl. Acad. Sci. USA 99 8 (2002) 5675-5679
13. B. Solomon, In vivo targeting of amyloid plaques via intranasal administration of phage anti-β-amyloid antibodies, AD/PD Conference Proceedings (2005), Adv. Behav. Biol. 57 (2008) 273-278.